Table 3. MiRNAs differentially expressed in SLE European American samples derived cell lines.
Differential Expression Type | MiRNA Name | Mean Ratio |
Up-regulated | hsa-miR-638 | 6.90±1.33 |
hsa-miR-328-5P | 6.45±1.50 | |
hsa-miR-1228* | 5.86±3.56 | |
hsa-miR-663 | 5.34±0.75 | |
hsa-miR-92B* | 5.07±3.91 | |
hsa-miR-371-5P | 4.92±1.20 | |
hsa-miR-675 | 4.88±2.00 | |
hsa-miR-125A-3P | 4.71±2.56 | |
hsa-miR-483-5P | 4.60±1.51 | |
hsa-miR-665 | 4.44±2.90 | |
hsa-miR-602 | 4.37±3.98 | |
hsa-miR-187* | 4.33±2.75 | |
hsa-miR-423-3P | 4.23±1.17 | |
hsa-miR-583 | 4.01±1.50 | |
hsa-miR-654-5P | 3.73±1.98 | |
hsa-miR-150* | 3.63±0.95 | |
hsa-miR-933 | 3.50±1.17 | |
hsa-miR-149* | 3.47±1.54 | |
hsa-miR-744 | 3.40±1.29 | |
hsa-miR-516A-5P | 3.31±0.65 | |
hsa-miR-373* | 3.25±1.01 | |
hsa-miR-550 | 3.15±1.50 | |
hsa-miR-92B | 3.05±0.91 | |
hsa-miR-181A | 3.03±1.98 | |
hsa-miR-320A | 2.82±1.47 | |
hsa-miR-30C-1* | 2.78±0.90 | |
hsa-miR-378 | 2.69±0.86 | |
hsa-miR-30B | 2.66±0.37 | |
hsa-miR-30D | 2.59±0.89 | |
hsa-miR-198 | 2.42±0.46 | |
hsa-miR-298 | 2.29±0.18 | |
hsa-miR-874 | 2.28±0.67 | |
hsa-miR-135A* | 2.14±0.64 | |
hsa-miR-765 | 2.03±0.57 | |
hsa-miR-659 | 1.98±0.53 | |
hsa-miR-193B | 1.95±0.30 | |
hsa-miR-494 | 1.83±1.54 | |
hsa-miR-222 | 1.75±0.81 | |
hsa-miR-142-3P | 1.74±1.45 | |
hsa-miR-29C | 1.66±0.15 | |
hsa-miR-140-3P | 1.61±0.68 | |
hsa-miR-148A | 1.61±1.31 | |
Down-regulated | hsa-miR-20A | 0.58±0.07 |
hsa-miR-26A | 0.53±0.09 | |
hsa-miR-768-3P | 0.50±0.11 | |
hsa-miR-1224-3P | 0.50±0.10 | |
hsa-miR-886-3P | 0.49±0.12 | |
hsa-miR-720 | 0.48±0.08 | |
hsa-miR-155 | 0.46±0.11 |